Hepatorenal Syndrome
📧 Sign up to get email alerts when something new happens for Hepatorenal Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure [NA]
Completed clinical trial comparing noradrenaline (norepinephrine) versus terlipressin for the response rate in hepatorenal syndrome among pa…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1 [Phase 3]
A Phase 3 study comparing terlipressin to placebo for hepatorenal syndrome Type 1 has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients [Phase 2]
Phase 2 safety and pharmacokinetics update for Ifetroban in patients with Hepatorenal Syndrome, with results posted in 2017.
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis
This clinical trial update evaluates the accuracy of NGAL, a renal injury biomarker, in patients with cirrhosis, including those with acute …
-
CLINICAL_TRIALS withdrawal · 2016-08-31Clinical Trial Update: To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome [NA]
A clinical trial evaluating noradrenaline with terlipressin versus stepped-up terlipressin therapy for hepatorenal syndrome has been withdra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome [Phase 1]
La Jolla Pharmaceutical's Phase 1 study of LJPC-501 in patients with Hepatorenal Syndrome was terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure [Phase 4]
Phase 4 clinical trial assessing whether terlipressin can prevent Type 2 hepatorenal syndrome by improving mean arterial pressure.
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: Plasma and Hemodynamic Markers During Hepatectomy
This clinical trial update describes a completed study evaluating plasma and hemodynamic markers during hepatectomy.
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: Single Pass Albumin Dialysis in Patients With Cirrhosis [Phase 1, Phase 2]
Clinical trial update indicating completion of Phase 1 and Phase 2 studies of Single Pass Albumin Dialysis in patients with cirrhosis and re…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome [Phase 2, Phase 3]
The document reports a Phase 2/3 clinical trial comparing intravenous bolus administration of terlipressin to continuous intravenous infusio…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome [Phase 2, Phase 3]
A Phase 2/Phase 3 randomized trial comparing terlipressin plus albumin to midodrine plus octreotide for hepatorenal syndrome in cirrhosis ha…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis [NA]
A clinical trial evaluating treatment for Type-1 Hepatorenal Syndrome associated with sepsis has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: TYPE 2 HEPATORENAL SYNDROME [Phase 3]
Phase 3 trial assessing the safety and efficacy of terlipressin plus norepinephrine for Type 2 hepatorenal syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome [NA]
A clinical trial examining angiogenic factors in the development of hepatorenal syndrome (NCT00734136) was terminated by the sponsor (Lahey …
-
CLINICAL_TRIALS trial_result · 2008-04-11Clinical Trial Update: Noradrenalin vs Terlipressin in Hepatorenal Syndrome [Phase 3]
Phase 3 trial comparing noradrenaline to terlipressin for hepatorenal syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-11Clinical Trial Update: Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin [Phase 4]
A Phase 4 trial evaluating terlipressin plus albumin versus albumin for hepatorenal syndrome has been suspended.
-
CLINICAL_TRIALS trial_result · 2006-08-03Clinical Trial Update: Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis [Phase 4]
Phase 4 trial evaluating Norfloxacin for primary prophylaxis of spontaneous bacterial peritonitis has completed. The study includes patients…